Interleukin-12 in Treating Patients With Advanced Cancer

Clinical trial NCT00003330 · COMPLETED

Trial details

NCT number: NCT00003330
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1998-07-01
Primary completion: 2002-04-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.